or Try an Advanced Search...

    ETF Components for PPH - Market Vectors Pharmaceutical ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY F -1.40 11.57
    NVO D -2.66 7.69
    JNJ D 0.10 6.86
    MCK A 0.66 6.08
    BMY B -0.22 5.89
    ABBV F 0.29 5.76
    COR B -0.16 5.18
    NVS D 0.29 5.01
    MRK F 0.18 4.80
    ZTS D 0.00 4.68
    TAK D 0.11 4.60
    HLN C 0.79 4.56
    AZN F 0.89 4.41
    SNY F 0.06 4.26
    PFE F -0.28 4.23
    GSK F -0.06 3.88
    TEVA C 0.15 3.65
    VTRS A 0.04 2.27
    CTLT D 0.00 1.14
    JAZZ B 1.59 1.11
    ELAN D -0.19 0.65
    OGN F 0.48 0.57
    PRGO C -0.92 0.49
    PDCO F -0.20 0.24

    Represented by ETF Holdings

    Keywords: Pharmaceutical Products S&P 500 Pharmaceutical Animal Health Life Sciences Antibiotics Biopharmaceutical Cancer Drugs Medication Pain Biotechnology Depressive Disorder Diabetes Hypertension Infection Infectious Diseases Active Pharmaceutical Ingredients Gastrointestinal Health Products
    Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Distribution Biotechnology Drug Manufacturers - General

    Recent News for Market Vectors Pharmaceutical ETF & its Holdings

    Date Stock Title
    Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
    Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
    Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
    Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
    Nov 21 TEVA Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
    Nov 20 ZTS Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
    Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
    Nov 20 SNY CDC warns of an imminent spike in COVID, flu cases
    Nov 20 GSK CDC warns of an imminent spike in COVID, flu cases
    Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
    Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
    Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
    Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
    The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Depositary Receipt
    Back to the Main PPH Page...